The Clorox Company $CLX Stock Position Lifted by Tobam

Tobam increased its position in shares of The Clorox Company (NYSE:CLX) by 16.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,784 shares of the company’s stock after acquiring an additional 7,048 shares during the period. Clorox comprises approximately 2.3% of Tobam’s portfolio, making the stock its 11th biggest holding. Tobam’s holdings in Clorox were worth $5,857,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of Clorox by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after acquiring an additional 65,924 shares during the last quarter. Northern Trust Corp grew its holdings in Clorox by 2.3% during the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after purchasing an additional 34,655 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Clorox by 7.4% in the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock worth $200,512,000 after buying an additional 94,371 shares during the last quarter. ProShare Advisors LLC boosted its holdings in shares of Clorox by 7.0% during the 2nd quarter. ProShare Advisors LLC now owns 1,160,881 shares of the company’s stock worth $139,387,000 after buying an additional 75,514 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Clorox by 3.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after buying an additional 41,485 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on CLX shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a $152.00 price target on shares of Clorox in a research report on Tuesday, November 4th. UBS Group set a $119.00 price objective on shares of Clorox and gave the stock a “neutral” rating in a report on Tuesday, November 4th. TD Cowen cut their price target on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 4th. Finally, Rothschild & Co Redburn lowered their price target on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $125.69.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.63% of the company’s stock.

Clorox Stock Up 0.3%

NYSE CLX opened at $104.99 on Wednesday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 52 week low of $104.08 and a 52 week high of $171.37. The stock has a market capitalization of $12.81 billion, a P/E ratio of 16.10, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The stock has a fifty day moving average of $118.92 and a 200-day moving average of $124.26.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter last year, the business earned $1.86 earnings per share. The firm’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd were paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s dividend payout ratio is presently 77.86%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.